Other Controls and Reagents
Avanti Polar Lipids 20:4 PG 25MG
20:4 PG1,2-diarachidonoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt)
Cayman Chemical Lyso-PAF C-18 5mg
Lyso-PAF C-18 can be formed by either the action of PAF-AH on PAF C-18{2626} or by the action of a CoA-independent transacylase on 1-O-octadecyl-2-acyl-glycerophosphocholine.{240,2098} Lyso PAF C-18 is a substrate for eitherPAF C-18 formation by the remodeling pathway{939} or selective acylation with arachidonic acid by a CoA-independent transacylase.{2101}
Medchemexpress LLC Dspe-peg2000-cooh | 1445832-74-5 | 99.95% | 2000 (Average) | 100 MG
DSPE-PEG2000-COOH is a pegylated derivative of 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine. It is designed to form micelles for targeted drug delivery.
- Forms micelles for targeted drug delivery
- Pegylated derivative
Apexbio Technology LLC DMG-PEG2000-N3 50mg
DMG-PEG2000-N3 is a PEGylated lipid derivative utilized for the functionalization of lipid-based drug delivery systems It consists of 1 2-dimyristoyl-sn-glycerol (DMG) polyethylene glycol (PEG 2000 Da) and a terminal azide group (N3) The azide functional group enables selective conjugation via copper-catalyzed azide-alkyne cycloaddition (CuAAC or click chemistry) allowing controlled attachment of biomolecules small-molecule drugs fluorescent probes or targeting ligands onto lipid bilayers DMG-PEG2000-N3 is widely applied in the development of liposomal or nanoparticle formulations for targeted drug delivery and imaging in biomedical research
Cayman Chemical 1 3DIoleoyl2Octnoyl Glyce 5mg
A triacylglycerol; been used to characterize the functionality of R. oryzae lipase for regiodistribution analysis of fats containing medium- and short-chain fatty acids
(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC | 1mg | 779524049](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502460679.PNG-250.jpg)
eMolecules 62600-81-1 | 1-Palmitoyl-2-Oleoyl-sn-glycero-3-PA (solution in chloroform) | Broadpharm | MFCD05864230 | 674.941 | C37H71O8P | 0.000 | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC | 1mg | 779524049
1-Palmitoyl-2-Oleoyl-sn-glycero-3-PA (solution in chloroform) | Broadpharm | 62600-81-1 | MFCD05864230 | 674.941 | C37H71O8P | 0.000 | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC | 1mg | 779524049
Cayman Chemical DLIn-MC3-DMA 25mg
An ionizable cationic lipid (apparent pKa = 6.44); has been used in the generation of lipid nanoparticles (LNPs) encapsulating siRNA, mRNA, or plasmid DNA for use in vitro and in vivo; LNPs containing DLin-MC3-DMA accumulate in the muscle and non-draining lymph nodes after intramuscular administration and in the spleen after intravenous administration in mice; LNPs containing DLin-MC3-DMA and encapsulating F7 siRNA reduce hepatic and plasma Factor VII levels in mice without inducing liver toxicity
Cayman Chemical 1 3DIoloyl2ElaIdoyl Glyce 10mg
A triacylglycerol; has been used to study the effects of unsaturation and sn-2 substitution on the polymorphic behavior of triacylglycerols
Avanti Polar Lipids OXIDIZ 1-PALMIT 1-2-ARAC 500UG
Oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine 500UG
(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC#CC#CCCCCCCCCCC | 25mg | 718091956](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502474712.JPG-250.jpg)
eMolecules 84271-00-1 | PTPC | Broadpharm824.178 | C47H86NO8P | 0.000 | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC#CC#CCCCCCCCCCC | 25mg | 718091956
PTPC | Broadpharm | 84271-00-1824.178 | C47H86NO8P | 0.000 | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC#CC#CCCCCCCCCCC | 25mg | 718091956
Avanti Polar Lipids 18:1 PI(3,4)P2 1,2-DIOLEOYL-SN
18:1 PI(3,4)P2 1,2-dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate) (ammonium salt) 100ug